FIA
ATRS

Foundations Investment Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

Foundations Investment Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,870
Closed -$43K – 142
2019
Q3 		$43K Hold
12,870
– – 0.01% 128
2019
Q2 		$44K Hold
12,870
– – 0.01% 119
2019
Q1 		$39K Hold
12,870
– – 0.01% 97
2018
Q4 		$42K Buy
+12,870
New +$42.4K 0.01% 103

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Foundations Investment Advisors's ATRS Position: Q4 2019 in Review

Foundations Investment Advisors sold out of Antares Pharma, Inc. (ATRS) in Q4 2019, closing a stake of 12,870 shares — an estimated $43K sold.

Foundations Investment Advisors first reported a position in ATRS in Q4 2018 and held it in 4 quarters. The position peaked at $44K in Q2 2019. 160 funds tracked by Wall St. Rank hold ATRS as of Q4 2019.

  • Foundations Investment Advisors reported no remaining Antares Pharma, Inc. position as of Q4 2019 after selling out during the quarter.
  • Foundations Investment Advisors sold 12,870 Antares Pharma, Inc. shares in Q4 2019, an estimated $43K.
  • Foundations Investment Advisors first reported a position in Antares Pharma, Inc. in Q4 2018 and held it in 4 quarters.
  • Foundations Investment Advisors's Antares Pharma, Inc. position peaked at $44K in Q2 2019.
  • 160 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2019.

Based on Foundations Investment Advisors's 13F filing for Q4 2019, filed 9 Jan 2020.